- Filed
- Apr 24, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Mar 31, 2025 | 195.1M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $5.06B |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $5.08B |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $70.6M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $70.6M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $609.9M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $679.5M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $4.39B |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $4.22B |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $888.5M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $1.06B |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $6.46B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $6.67B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $1.82B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $1.8B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $10.95B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $10.98B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 195.3M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $0 |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $20.8M |
| Capex | Q1 2025 · Mar 31, 2024 | $62.4M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $54M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.33 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.34 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $305.6M |
| Net Income | Q1 2025 · Mar 31, 2024 | $65.1M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $157.2M |
| Revenue | Q1 2025 · Mar 31, 2024 | $1.02B |